Literature DB >> 4104491

Predicting response to levodopa.

J P Lakke, J Korf, H M van Praag.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4104491     DOI： 10.1016/s0140-6736(71)92338-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Correlation of clinical symptoms, HVA and 5-HIAA in csf and plasma L-DOPA in Parkinsonian patients treated with L-DOPA and L-DOPA + RO 4-4602.

Authors:  G Campanella; S Algeri; C Cerletti; E Dolfini; A Jori; F Rinaldi
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

2.  Relationship of age and mood to monoamine metabolites in cerebrospinal fluid in parkinsonism.

Authors:  A K Granerus; T Magnusson; B E Roos; A Svanborg
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

Review 3.  Clinical pharmacokinetics of levodopa in parkinson's disease.

Authors:  J R Bianchine; G M Shaw
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

4.  CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders.

Authors:  D L Davidson; C M Yates; C Mawdsley; I A Pullar; H Wilson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-12       Impact factor: 10.154
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.